CX3CR1 agonist (The University of Texas MD Anderson Cancer Center)

N/A

Report date: 2025/06/11 10:46:42
NME

Base Information

Drug NameCX3CR1 agonist (The University of Texas MD Anderson Cancer Center)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionC-X3-C motif chemokine receptor 1 agonistsNeuroprotectants
TargetsC-X3-C motif chemokine receptor 1
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A